Grace Dai
Investor / Seed/Early
New York, US

About Grace
Grace Dai is an investor in Bessemer’s New York City office.
Prior to joining Bessemer full time, Grace led Critical VC’s University of Pennsylvania team, where she oversaw a group of undergraduate and MBA students investing in startups across health care, climate and economic mobility. She was also a summer analyst at Bessemer.
Grace holds a bachelor’s degree and a master’s degree in computational biology from the University of Pennsylvania. She also led the data analytics team at the Daily Pennsylvanian, the podcast team for the Penn Biotech Society, and founded the university’s Alternative Protein Project in 2023 under The Good Food Institute.
Outside of work, she enjoys hiking, diving, fermenting foods and making jewelry.
AI
Biotech
Healthcare
Enterprise
Infrastructure
Physical AI & Robotics
Vertical
Q&A
1 / 3
The city that made you is...
Wheeling, WV, and Kona, HI.
Latest News & Research
3 Total Posts
News
Boltz: building towards programmable molecular design
Bessemer Venture Partners leads Boltz's $110M Series A to back the team behind the state-of-the-art protein and small molecule foundation models for AI drug discovery.

News
Flagler Health: The AI-native solution for musculoskeletal care
Bessemer Venture Partners leads Flagler Health's $50M Series B to build the AI-powered operating system for the $400B MSK market.

Roadmap
Building biology-native data infrastructure for the AI era
As compute costs fall and models mature, sustaining a competitive edge in global drug development requires innovation across the entire data infrastructure stack. Biology-native data, agentic workflows, and lab automation will define the next generation of leading biotechs.